Verastem Net Income Quarterly:
-7.921M for Dec. 31, 2012Verastem Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -7.921M |
| Sept. 30, 2012 | -10.37M |
| June 30, 2012 | -6.825M |
| March 31, 2012 | -6.871M |
| Dec. 31, 2011 | -6.005M |
| Sept. 30, 2011 | -4.047M |
| June 30, 2011 | -2.485M |
| March 31, 2011 | -1.146M |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
VSTM Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| AVEO Pharmaceuticals | -34.08M |
| ARCA biopharma | -0.84M |
| Sangamo BioSciences | -3.478M |
VSTM Net Income Quarterly Rankings
| Overall |
38th percentile 4938 of 8005 |
| Sector |
23rd percentile 525 of 686 in Healthcare |
| Industry |
36th percentile 157 of 248 in Biotechnology |
VSTM Net Income Quarterly Range, Past 5 Years
| Minimum | -10.37M | Sep 2012 |
| Maximum | -1.146M | Mar 2011 |
| Average | -5.708M |
